Rhumbline Advisers increased its stake in shares of Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) by 21.0% in the second quarter, Holdings Channel reports. The firm owned 49,276 shares of the company’s stock after buying an additional 8,541 shares during the quarter. Rhumbline Advisers’ holdings in Quipt Home Medical were worth $159,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Pinnacle Wealth Planning Services Inc. acquired a new position in shares of Quipt Home Medical during the 1st quarter worth about $50,000. Bank of New York Mellon Corp grew its holdings in Quipt Home Medical by 32.8% during the second quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock valued at $418,000 after purchasing an additional 32,073 shares during the period. Boston Partners increased its stake in Quipt Home Medical by 12.8% in the first quarter. Boston Partners now owns 742,006 shares of the company’s stock valued at $3,243,000 after purchasing an additional 84,182 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in Quipt Home Medical by 2.4% in the first quarter. Russell Investments Group Ltd. now owns 511,348 shares of the company’s stock worth $2,235,000 after purchasing an additional 12,070 shares during the period. Finally, Bridge City Capital LLC boosted its position in shares of Quipt Home Medical by 17.9% during the first quarter. Bridge City Capital LLC now owns 47,721 shares of the company’s stock worth $209,000 after purchasing an additional 7,244 shares in the last quarter. Institutional investors own 42.85% of the company’s stock.
Quipt Home Medical Stock Performance
Shares of Quipt Home Medical stock opened at $2.80 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.11 and a quick ratio of 0.77. The firm has a market cap of $119.20 million, a price-to-earnings ratio of -28.00 and a beta of 0.60. The stock’s 50-day moving average is $3.07 and its 200-day moving average is $3.41. Quipt Home Medical Corp. has a one year low of $2.60 and a one year high of $5.44.
Analysts Set New Price Targets
Several brokerages recently commented on QIPT. Canaccord Genuity Group dropped their price objective on Quipt Home Medical from $8.00 to $6.00 and set a “buy” rating on the stock in a research note on Friday, August 16th. Benchmark cut their price objective on Quipt Home Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Wednesday, August 21st. Finally, Ventum Cap Mkts raised Quipt Home Medical to a “strong-buy” rating in a research note on Tuesday, July 16th. One analyst has rated the stock with a sell rating, three have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $6.25.
Read Our Latest Research Report on QIPT
Quipt Home Medical Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Read More
- Five stocks we like better than Quipt Home Medical
- CD Calculator: Certificate of Deposit Calculator
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- What is the FTSE 100 index?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is Insider Trading? What You Can Learn from Insider Trading
- MarketBeat Week in Review – 9/23 – 9/27
Want to see what other hedge funds are holding QIPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report).
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.